Our Management Board currently consists of five members. The international composition and the varied responsibilities reflect our global operations.
The Management Board and the Supervisory Board of Fresenius Medical Care AG (Company) report below on the fiscal year 2023 (the year under review) pursuant to Sections 289f, 315d of the German Commercial Code (Handelsgesetzbuch – HGB) and in accordance with principle 23 of the German Corporate Governance Code in the version dated April 28, 2022 (GCGC), as published in the German Federal Gazette (Bundesanzeiger) on June 27, 2022, on the Company’s corporate governance (Unternehmensführung) and also comment on recommendations and suggestions of the GCGC.
Declaration on Corporate Governance 2023
PDF, 283 KBDeclaration on Corporate Governance 2022
PDF, 525 KBDeclaration on Corporate Governance 2021
PDF, 719 KBDeclaration on Corporate Governance 2020
PDF, 706 KBDeclaration on Corporate Governance 2019
PDF, 329 KBDeclaration on Corporate Governance 2018
PDF, 360 KBDeclaration on Corporate Governance 2017
PDF, 1 MBDeclaration on Corporate Governance 2016
PDF, 1 MB